• 대한세포병리학회지
• /
• 제7권2호
• /
• pp.197-201
• /
• 1996

Glassy cell carcinoma is an unusual neoplasm of the uterine cervix that accounts for $1{\sim}2%$ of all cervical malignancy. It is a rapidly progressive and biologically aggressive disease with poor response to therapy. This tumor is considered to be a poorly differentiated mixed adenosquamous carcinoma. The cytologic findings are characterized by tumor cells arranged predominantly in syncytial like aggregates and an inflammatory background. The tumor cells have moderate amounts of eosinophilic or amphophilic cytoplasm, which is often finely granular. The nuclei are relatively large and have fine chromatin with prominent eosinophilic nucleoli. Cytologically, glassy cell carcinoma is most likely to be confused with large cell nonkeratinizing squamous cell carcinoma and with atypical reparative cells. Herein, we report three cases of glassy cell carcinoma of the uterine cervix diagnosed by cervicovaginal smear and confirmed by histologic section with review of literatures.

• 대한세포병리학회지
• /
• 제2권1호
• /
• pp.62-66
• /
• 1991

Glassy cell carcinoma is an unusual neoplasm of the uterine cervix with highly aggressive clinical behavior. On cervico-vaginal smear examination, the tumor has well confused of atypical repair ceil of the endocervix. Recently, we have experienced two cases of glassy cell carcinoma of the uterine cervix, diagnosed on cervico-vaginal smears and confirmed on fellowing histologic sections. The cervico-vaginal smears revealed abundant clusters with well defined boarders. The cell clusters were composed of large tumor cells. The tumor cells had distinct granular cytoplasm and eosinophilic macronucleoli, Characteristic cytologic features of this tumor were discussed in view of differential diagnosis.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권1호
• /
• pp.353-356
• /
• 2016

Background: This study used receiver operating characteristic curve to analyze Surveillance, Epidemiology and End Results (SEER) for glassy cell carcinoma data to identify predictive models and potential disparities in outcome. Materials and Methods: This study analyzed socio-economic, staging and treatment factors. For risk modeling, each factor was fitted by a generalized linear model to predict the cause specific survival. Area under the receiver operating characteristic curves (ROCs) were computed. Similar strata were combined to construct the most parsimonious models. A random sampling algorithm was used to estimate modeling errors. Risk of glassy cell carcinoma death was computed for the predictors for comparison. Results: There were 79 patients included in this study. The mean follow up time (S.D.) was 37 (32.8) months. Female patients outnumbered males 4:1. The mean (S.D.) age was 54.4 (19.8) years. SEER stage was the most predictive factor of outcome (ROC area of 0.69). The risks of cause specific death were, respectively, 9.4% for localized, 16.7% for regional, 35% for the un-staged/others category, and 60% for distant disease. After optimization, separation between the regional and unstaged/others category was removed with a higher ROC area of 0.72. Several socio-economic factors had small but measurable effects on outcome. Radiotherapy had not been used in 90% of patients with regional disease. Conclusions: Optimized SEER stage was predictive and useful in treatment selection. Underuse of radiotherapy may have contributed to poor outcome.

• Radiation Oncology Journal
• /
• 제24권2호
• /
• pp.123-127
• /
• 2006

목적: 7예의 자궁경부의 유리세포암 초기 병기 환자들을 통하여 임상적 특징, 병리조직학적 소견, 치료방법 및 예후를 알아보고자 하였다. 대상 및 방법: 1993년 1월부터 2005년 12월까지 계명의대 동산의료원에서 병리조직학적으로 자궁경부암기 유리세포암으로 확인된 FIGO 병기 IB 6예와 IIA환자 1예, 모두 7예의 환자를 대상으로 하였으며 이들 중 1예의 IB 환자에서는 자궁 내 임신 22주 상태였다. 환자들의 의무기록을 통하여 임상적 특징, 병리조직학적 소견, 치료방법 및 예후를 분석하였다. 진단은 병리조직학적으로 유리세포암의 특징적 소견을 보이는 세포들로 50% 이상 구성되어있을 때 유리세포암으로 진단하였다. FIGO 임상병기 IB인 6명의 환자에서 근치적 자궁절제술 및 양측 골반 림프절 절제술을 시행하였으며 이들 중 2명은 수술 후 동시 항암화학방사선요법을 받았다. 1예의 IIA 환자는 동시 항암화학방사선요법으로 근치적 방사선치료를 시행하였다. 결과: 조직학적으로 자궁경부암으로 진단 받은 전체 환자 3,745명 중 유리세포암 환자는 7명이었다(0.2%). 7예의 자궁경부 유리세포암 환자의 평균 연령은 44세였으며, 연령 분포는 35세에서 53세까지였다. 가장 흔한 증상은 질 출혈로 7예 중 5예에서 나타났다(86%). 치료 전 시행한 펀치 생검 소견으로 전체 7예에서 2예에서만 유리세포암으로 진단 가능하였으며, 나머지 5예는 선편평상피세포암 1예, 미분화 선암 2예, 편평상피세포암 2예로 진단되었으나, 수술 후 병리조직학적 검사에서 유리세포암으로 확진되었다. 추적관찰기간은 13개월에서 150개월이며, 평균 추적기간은 73개월로 모두 무병상태로 생존하고 있다. 결론: 자궁경부의 유리세포암은 비록 공격적이고 악성도가 높은 종양이지만, 초기 암 환자는 정확한 병기평가와 근치적 수술 후 동시 항암화학방사선치료와 같은 적극적인 보조치료를 시행하면 보다 향상된 생존율을 얻을 수 있을 것으로 예상된다.

• 대한세포병리학회:학술대회논문집
• /
• 대한세포병리학회 1991년도 제5차 춘계학술대회 초록집
• /
• pp.15.1-15.1
• /
• 1991

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제16권2호
• /
• pp.196-201
• /
• 1994

One case of an unusual form of carcinoma involving the submucosal gland and duct of tongue was reported and reviewed. According to Gerughty et al(1968) four distinct component parts were classified : ductal carcinoma in situ(involvement of the ductal epithelium by in situ carcinomatous changes), squamous cell carcinoma, and a mixed carcinoma(combination of glandular and squamous characteristics and occasionally consisted of large nests composed of "glassy" cell). This tumor was fond to be extremely aggressive and highly malignant. The histopathologic features and the clinical behavior of this tumor were sufficiently distinctive to warrant the designation adenosquamous carcinoma : exhibit concomitant glandular and squamous neoplasm. The mode of therapy was evaluated and the treatment of choice appears to be radical surgery. So, we has done the radical neck dissection and partial glossectomy. However, the limited number of cases indicated that collection and subsequent analysis of additional cases must be performed before any definitive conclusion can be drawn.